Sponsor:
Columbia University
Code:
NCT06456268
Conditions
ACL
Opioid Use
Cryotherapy Effect
Vibration; Exposure
Pain, Postoperative
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Interventions
VibraCool mechanical stimulation and neuromodulatory therapeutic device
Cryocompression (Game Ready, Bregs) device
Standard ice packs
Brief summary:
Conditions
ACL
Opioid Use
Cryotherapy Effect
Vibration; Exposure
Pain, Postoperative
Study ID
NCT06456268
Start date
Jun, 2026
Status verified date
Jan, 2026
Completion date
Nov 30, 2026
Anticipated
Primary completion date
Nov 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Enrollment
130 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Standard Ice packs
active comparator: Cryocompression device
experimental: VibraCool
Interventions
VibraCool mechanical stimulation and neuromodulatory therapeutic device
Cryocompression (Game Ready, Bregs) device
Standard ice packs
Primary outcome measure
Locations
Columbia University Medical Center
Recruiting
New York, New York, United States, 10032
Contacts
Sponsor
Columbia University
Last update posted
Jan 7, 2026
Last verified
Jan, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-10. This information was provided to ClinicalTrials.gov by Columbia University on 2026-01-07. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.